New Harbor Capital Launches New ENT Platform; Waypoint Capital Acquires Allergy Partners
The fourth quarter of 2021 delivered six reported ENT practice acquisition, marking the highest ENT acquisition quarter we have seen to date.
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC
© 2024 FOCUS Investment Banking LLC
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC
Member of M&A Worldwide 